Ulthera Announces Issuance of Patent for New Medical Field of Use

Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – announces the issuance of U.S. Patent No. 8,282,554 this week from the U.S. Patent and Trademark Office (USPTO). The patent, titled “Methods for Treatment of Sweat Glands” relates to the therapeutic use of energy for the treatment of conditions resulting from sweat gland disorders, such as hyperhidrosis.Continue reading

Ulthera Receives First-Ever FDA Clearance for Non-invasive Lift of Skin on the Neck and Under the Chin

Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively lift lax tissue on the neck and the submental (under the chin). Continue reading